Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Erasca Inc (NQ: ERAS )

3.300 +0.410 (+14.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,282,215
Open 2.940
Bid (Size) 3.300 (1)
Ask (Size) 3.600 (1)
Prev. Close 2.890
Today's Range 2.930 - 3.370
52wk Range 2.490 - 10.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. 
Via Benzinga
Earnings Scheduled For May 26, 2023
Companies Reporting Before The Bell • LightInTheBox Holding (NYSE:LITB) is estimated to report earnings for its first quarter. 
Via Benzinga

Performance

YTD
-22.54%
-22.54%
1 Month
+15.38%
+15.38%
3 Month
-4.35%
-4.35%
6 Month
-54.67%
-54.67%
1 Year
-40.00%
-40.00%

More News

Read More
Erasca Earnings Preview
Via Benzinga
Erasca Reports First Quarter 2023 Financial Results and Business Updates
From Erasca, Inc.
Via GlobeNewswire
$4M Bet On Jasper Therapeutics? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
Via Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
US Stocks Open Higher, Dow Jumps Over 200 Points
Via Benzinga
Erasca And 2 Other Stocks Under $3 Insiders Are Aggressively Buying
Via Benzinga
Erasca Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Business Updates
From Erasca, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Over $4 Million Bet On Werewolf Therapeutics? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Erasca to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Erasca, Inc.
Via GlobeNewswire
Red Cat Holdings And 2 Other Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Erasca Announces First Patient Dosed in HERKULES-1 Phase 1b Trial Evaluating ERAS-007 and ERAS-601 MAPKlamp Combination in RAS/MAPK Pathway-Altered Solid Tumors
From Erasca, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Erasca Announces FDA Clearance of IND Application for CNS-Penetrant KRAS G12C Inhibitor ERAS-3490 in KRAS G12C-Mutated Advanced or Metastatic Solid Tumors
From Erasca, Inc.
Via GlobeNewswire
RH, HUYA, Bilibili And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Lululemon, Li Auto, Hackett Group And Some Other Big Stocks Moving Lower On Friday
Via Benzinga
Erasca Oulicenses Its Mid-Stage Cancer Program To Novartis, Raises $100M Via Equity Offering
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.